α-Synuclein and the Parkinson's disease-related mutant Ala53Thr-α- synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells

Neuroscience Letters

Volumn 285, Issue 2, 2000, Pages 79-82

  Ancolio, K ^a   Alves Da Costa, C ^a   Ueda K ^b   Checler, F ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Synuclein; Ala53Thr synuclein; Alzheimer's disease; Degradation; HEK293 cells; Neurons; Parkinson disease; Proteasome

Indexed keywords

ALANINE; ALPHA SYNUCLEIN; MUTANT PROTEIN; THREONINE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FAMILIAL DISEASE; HUMAN; HUMAN CELL; LEWY BODY; MOUSE; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALANINE; ALPHA-SYNUCLEIN; AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; CYSTEINE ENDOPEPTIDASES; HUMANS; MICE; MULTIENZYME COMPLEXES; MUTATION; NERVE TISSUE PROTEINS; NEURONS; PARKINSON DISEASE; PROTEASOME ENDOPEPTIDASE COMPLEX; SYNUCLEINS; THREONINE; TRANSFECTION;

EID: 0034640160     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01049-1     Document Type: Article

References (21)

1. Alves da Costa C., Ancolio K., Checler F. C-terminal maturation fragments of presenilin 1 and 2 control secretion of APPα and Aβ by human cells and are degraded by the proteasome. Mol. Med. 5:1999;160-168.
2. Ancolio K., Dumanchin C., Barelli H., Warter J.M., Brice A., Campion D., Frébourg T., Checler F. Unusual phenotypic alteration of β amyloid precursor protein (βAPP) maturation by a new Val->Met βAPP-770 mutation responsible for probable early-onset Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 96:1999;4119-4124.
3. Arima K., Uéda K., Sunohara N., Hirai S., Izumiyama Y., Tonozuka-Uehara H., Kawai M. Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Res. 808:1998;93-100.
4. Arima K., Uéda K., Sunohara N., Arakawa K., Hirai S., Nakamura M., Tonozuka-Uehara H., Kawai M. NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol. 96:1998;439-444.
5. Bennett M.C., Bishop J.F., Leng Y., Chock P.B., Chase T.N., Mouradian M.M. Degradation of α-synuclein by proteasome. J. Biol. Chem. 274:1999;33855-33858.
6. Chun J., Jaenisch R. Clonal cell lines produced by infection of neocortical neuroblasts using multiple oncogenes transduced by retroviruses. Mol. Cell. Neurosci. 7:1996;304-321.
7. Coux O., Tanaka K., Goldberg A. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65:1996;801-847.
8. Dick L.R., Cruikshank A.A., Destree A.T., Grenier L., McCormack T.A., Melandri F.D., Nunes S.L., Palombella V.J., Parent L.A., Plamondon L., Stein R.L. Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells. J. Biol. Chem. 272:1997;182-188.
9. Fenteany G., Standaert R., Lane W.S., Choi S., Corey E.J., Schreiber S.L. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science. 268:1995;726-731.
10. Ii K., Ito H., Tanaka K., Hirano A. Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly. J. Neuropathol. Exp. Neurol. 56:1997;125-131.
11. Krüger R., Kuhn W., Müller T., Woitalla D., Graeber M., Kösel S., Przuntek H., Epplen J.T., Schöls L., Riess O. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat. Genet. 18:1998;106-108.
12. Kunkel T.A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA. 82:1985;488-492.
13. Kuzuhara S., Mori H., Izumiyama N., Yoshimura M., Ihara Y. Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study. Acta Neuropathol. (Berlin). 75:1988;345-353.
14. Marambaud P., Ancolio K., Lopez-Perez E., Checler F. Proteasome inhibitors prevent the degradation of familial Alzheimer's disease-linked presenilin 1 and trigger increased Aβ42 secretion by human cells. Mol. Med. 4:1998;147-157.
15. Marambaud P., Alves da Costa C., Ancolio K., Checler F. Alzheimer's disease-linked mutation of presenilin 2 (N141I-PS2) drastically lowers APPα secretion: control by the proteasome. Biochem. Biophys. Res. Commun. 252:1998;134-138.
16. Narhi L., Wood S.J., Steavenson S., Jiang Y., Wu G.M., Anafi D., Kaufman S.A., Martin F., Sitney K., Denis P., Louis J-C., Wypych J., Biere A.L., Citron M. Both familial Parkinson's disease mutations accelerate α-synuclein aggregation. J. Biol. Chem. 274:1999;9843-9846.
17. Okochi M., Walter J., Koyama A., Nakajo S., Baba M., Iwatsubo T., Meijer L., Kahle P.J., Haass C. Constitutive phsophorylation of the Parkinson's disease associated α-synuclein. J. Biol. Chem. 275:2000;390-397.
18. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnston W.G., Lazzarini A.M., Duvoisin R.C., Di lorio G., Golbe L.I., Nussbaum R.L. Mutation in the α-synuclein gene identified in families with Parkinson Disease. Science. 276:1997;2045-2047.
19. Spillantini M.G., Schmidt M.L., Lee V-Y., Trojanowski J.Q., Jakes R., Goedert M. α-synuclein in Lewy bodies. Nature. 388:1997;839-840.
20. Uéda K., Fukushima H., Masliah E., Xia Y., Iwai A., Yoshimoto M., Otero D.H.C., Kondo J., Ihara Y., Saitoh T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 90:1993;11282-11286.
21. Wilk S., Figueiredo-Pereira M. Synthetic inhibitors of the multicatalytic proteinase complex. Enzyme Protein. 47:1993;306-313.